Merit Medical Systems Inc (MMSI) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Total Assets Chart for Merit Medical Systems Inc
Merit Medical Systems Inc (MMSI) total assets for FY2025 were USD 2.7B, a 11.1% change from FY2024. Merit Medical Systems Inc's total assets grew from USD 1.6M in 1989 to USD 2.7B in 2025 (167770.1% over 36 years). Total assets compound annual growth rate: 5-year CAGR of 10.0%, 10-year CAGR of 13.2%, 20-year CAGR of 15.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $5.57B
- Implied Share Price
- $93.30
- Enterprise Value
- $5.58B
- Revenue (TTM)
- $1.58B
- EBITDA
- $338.94M
- Profit Margin
- 9.22%
- Trailing P/E
- 38.40
- Forward P/E
- 18.94
- Price/Book (MRQ)
- 3.10
- Price/Sales (TTM)
- 3.53
- EV/EBITDA
- 15.42
- EV/Revenue
- 3.54
- Dividend Yield
- —
- Book Value
- $28.13
- Free Cash Flow (FY2025)
- $212.53M
- Free Cash Flow Yield
- 3.82%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.